Publications
October 24, 2024

Novel CD33/CLL-1-directed dual CAR-T cells mediate potent antigen-specific cytolytic activity in mouse models of Acute Myeloid Leukemia (AML)

CD33-CLL1 Treatment System

ESGCT – 2024 – Oral Presentation OR085